Viewing Study NCT00913666


Ignite Creation Date: 2025-12-24 @ 4:43 PM
Ignite Modification Date: 2026-03-06 @ 10:11 PM
Study NCT ID: NCT00913666
Status: COMPLETED
Last Update Posted: 2009-06-04
First Post: 2009-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers
Sponsor: Biogen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Sclerosis View